Shourya Tripathi is a dedicated and passionate researcher in the field of Pharmaceutics, currently pursuing her PhD at the Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, India. With a strong academic foundation, she holds a Master of Science (Pharm.) in Pharmaceutics from NIPER-Raebareli (Gold Medalist, CGPA 9.82) and a Bachelor of Pharmacy from Kumaun University (Gold Medalist, 83.9%). Her research focuses on the design and development of brain-targeted drug delivery systems, with expertise in formulation development, and nanotechnology-based systems. Shourya has over six years of research experience, including in vitro and in vivo evaluations, animal studies. A recipient of the CSIR Research Fellowship and GPAT Fellowship, she is committed to interdisciplinary collaborations and aspires to contribute to cutting-edge innovations in drug delivery for neurodegenerative and other complex diseases. She has presented her work at various national and international conferences, winning awards such as the Best Poster Award.

Ashutosh Gupta is a dedicated pharmaceutical researcher currently pursuing a PhD in pharmaceutical science at Manipal College of Pharmaceutical Sciences, MAHE, Manipal, focusing on novel drug delivery systems for H. pylori infection and gastric ulcer treatment. He holds an M. Pharm in Pharmaceutics from BIT Mesra and a B. Pharm from Krishna Institute of Engineering & Technology, Ghaziabad. With extensive experience as a Research Scholar (ICMR-SRF, Dr. TMA Pai Fellow) and Research Assistant on a Dr. Reddy’s Laboratory-funded project, Ashutosh has authored 29 publications (H-index: 8) and secured 8 patents on drug quantification and formulation methods. His expertise spans formulation development, LC-MS, HPLC, and in-vivo studies, including diabetic wound and breast cancer models. Recognized with awards like the 2025 ANRF Travel Grant and 2023 Best Poster at MPCON, Ashutosh combines technical proficiency with a passion for advancing therapeutic solutions

Dr Yuhong Jiang earned a Bachelor's degree in Pharmacy and a Master's degree in Pharmaceutics, West China School of Pharmacy, Sichuan University. She obtained a Ph.D. in The University of Queensland under the supervision of Professor David Fairlie. Her primary research interest focuses on immune/inflammatory therapeutic targets and the molecular mechanisms of nano-formulated immune adjuvants in enhancing immune responses. She has also secured research funding as the principal investigator on projects including the National Natural Science Foundation of China (NSFC) grants. She has authored over 30 SCI-indexed research papers in leading international journals such as ACS Nano, Acta. Pharm. Sin. B, J. Control. Release, Biomaterials and Br. J. Pharmacol. and obtained 2 granted patents. Her publications feature a highest single-article impact factor of 17.1, a cumulative impact factor exceeding 200, and have garnered over 600 citations.

As a Biomedical Sciences Ph.D. candidate at the University of Macau, Yiyang Li possesses several years of experience and a robust skill set in the field of biomedical research, with a focus on ischemic stroke, neuroscience, nanomedicine, and the screening of Chinese medicinal compounds. He has actively contributed to multiple national and institutional research initiatives and has authored seven papers in SCI-indexed journals. Moreover, Yiyang Li has a commendable grasp of clinical practice and holds a license as a practicing Chinese medical physician.

He graduated from the Graduate School of Pharmaceutical Sciences at Kyoto University and was appointed Assistant Professor at the same institution in 1995. He was promoted to Associate Professor in 2002 and established his laboratory at Tokyo University of Science in 2017. He served as a postdoctoral research associate at the University of Pittsburgh from 1999 to 2001, and as a senior scientific research specialist at the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, from 2012 to 2014. He has received several awards, including the Pharmaceutical Society of Japan Award for Young Scientists (2004), the Academy of Pharmaceutical Science and Technology, Japan Award for Young Scientists (2007), and the Japan DDS Society Nagai Award (2017).

Dr. Lakshimipriya is a research scientist at the Vellore Institute of Technology (VIT), specializing in nanotechnology, regenerative medicine and various other drug delivery paradigms in the field of tissue engineering and biomedical research. She previously served as a Project Research Scientist at Christian Medical College (CMC), Vellore, where she contributed to infectious disease modeling and PK/PD analysis using hollow fiber infection models. With a Ph.D. in Biotechnology from VIT and over six years of research experience, her work focuses on the development of advanced nanofibrous scaffolds for diabetic wound healing, including the use of growth factor-impregnated biomaterials and silver nanocomposites. Dr. Lakshimipriya has published extensively in high-impact journals, holds multiple patents, and has received national and international recognition for her contributions to biomedical research.

Ngoc Duy Le earned his Bachelor of Pharmacy from Hanoi University of Pharmacy in 2017 and worked at the National Institute of Medicinal Materials in Vietnam. He began his Ph.D. studies at Yeungnam University, South Korea, in 2021 and completed his degree in 2025. He is currently a postdoctoral researcher at the Lab of Applied Nanomedicine, Yeungnam University. His research focuses on the development of targeted non-viral delivery vectors for nucleic acid therapeutics.